Dynamic Technology Lab’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Dynamic Technology Lab’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-21,423	Closed	-$153K	–	1505
2020 Q1	$153K	Buy	+21,423	New	+$267K	0.03%	834
2019 Q4	–	Sell	-18,716	Closed	-$502K	–	1444
2019 Q3	$502K	Buy	18,716 +10,079	+117%	+$283K	0.09%	422
2019 Q2	$234K	Buy	+8,637	New	+$271K	0.04%	755
2017 Q2	–	Sell	-8,413	Closed	-$330K	–	1442
2017 Q1	$330K	Buy	+8,413	New	+$268K	0.08%	517
2016 Q3	–	Sell	-15,986	Closed	-$377K	–	1264
2016 Q2	$377K	Buy	+15,986	New	+$395K	0.1%	399

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Dynamic Technology Lab's PTLA Position: Q2 2020 in Review

Dynamic Technology Lab sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 21,423 shares — an estimated $153K sold.

Dynamic Technology Lab first reported a position in PTLA in Q2 2016 and held it in 5 quarters. The position peaked at $502K in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Dynamic Technology Lab reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Dynamic Technology Lab sold 21,423 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $153K.
Dynamic Technology Lab first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 5 quarters.
Dynamic Technology Lab's Portola Pharmaceuticals, Inc. position peaked at $502K in Q3 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Dynamic Technology Lab's 13F filing for Q2 2020, filed 14 Aug 2020.